By Frank Prenesti
Date: Tuesday 30 Jul 2024
(Sharecast News) - US pharma giant Pfizer lifted its full-year profit forecast on Tuesday after second-quarter sales of its Covid vaccine and antiviral treatment came in better than expected, along with contributions from new cancer treatments and sales of its heart disease drug.
By Abigail Townsend
Date: Wednesday 01 May 2024
(Sharecast News) - Pfizer raised its full-year earnings forecast on Wednesday, on the back of solid demand for its non-Covid products.
By Michele Maatouk
Date: Tuesday 19 Mar 2024
(Sharecast News) - Haleon said on Tuesday that Pfizer has sold a larger-than-expected stake in the consumer healthcare group, taking its interest down to 22.6% from 32%.
Currency | US Dollars |
Share Price | $ 29.09 |
Change Today | $ 0.12 |
% Change | 0.41 % |
52 Week High | $33.94 |
52 Week Low | $25.26 |
Volume | 25,007,149 |
Shares Issued | 5,646m |
Market Cap | $164,242m |
Beta | 0.18 |
RiskGrade | 102 |
Strong Buy | 3 |
Buy | 6 |
Neutral | 15 |
Sell | 0 |
Strong Sell | 0 |
Total | 24 |
Time | Volume / Share Price |
16:02 | 2,861,250 @ $29.09 |
15:59 | 174 @ $29.09 |
15:59 | 100 @ $29.09 |
15:59 | 100 @ $29.11 |
15:59 | 100 @ $29.11 |
You are here: research